RenovoRx, Inc., which is developing targeted oncology therapies and commercializing its FDA-cleared RenovoCath drug-delivery devi ...

Imperative Care announced that the initial patients have been enrolled in the ADAPT 2.0 clinical study of continuous dual ...

Stryker announced that it has signed a definitive agreement to acquire Amplitude Vascular Systems, Inc. (AVS), which is a private ...

The Society of Interventional Radiology (SIR) announced results from the C-TRACT study, which is investigating the treatment of p ...

Pivotal DOORwaY90 trial evaluated Sirtex Medical’s Y90 selective internal radiation therapy to treat unresectable HCC.

Penumbra, Inc. announced 90-day results of the STORM-PE randomized controlled trial (RCT) that is evaluating computer-assisted va ...

The Society of Interventional Radiology (SIR) announced that the CAPTAIN randomized clinical trial found that men with ...

Reflow Medical, Inc. announced 12-month results from the DEEPER REVEAL clinical trial. According to the company, the ...

Cook Medical and Siemens Healthineers introduced their integrated interventional MRI (iMRI) suite at SIR 2026, the Society of ...

Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral ...

CUC America, a provider of advanced vascular and interventional care, announced strategic collaborations with Yuji Okuno, MD, ...

BD (Becton, Dickinson and Company) announced European CE Mark approval for the Liverty transjugular intrahepatic portosystemic sh ...